The Reuse of Immunoadsorption Columns in ABO-Incompatible Kidney Transplantation Is Efficient
Authors:
- Daniel C. SteinemannDSDaniel C. Steinemann
- Karine HadayaKHKarine Hadaya
- Uyen Huynh-DoUHUyen Huynh-Do
- Ute EisenbergerUte Eisenberger
- Isabelle BinetIBIsabelle Binet
- Thomas FehrTFThomas Fehr
- Michael DickenmannMDMichael Dickenmann
- 1 May 2015
- journal article
- research article
- Published by Wolters Kluwer Health in Transplantation
- Vol. 99 (5) , 1030-1035
Abstract
We developed a multicentric Swiss protocol for ABO-incompatible kidney transplantation including immunoadsorption column reuse. The aim of this study was to assess efficacy and safety of immunoadsorption column reuse in ABO-incompatible kidney transplantation. We performed a multicentric prospective trial including all ABO-incompatible kidney transplantations in Switzerland from 2005 to 2011. Patients received rituximab and standardized immunosuppression with tacrolimus, mycophenolate mofetil, and steroids. Antigen-specific perioperative immunoadsorption was performed. Immunoadsorption columns were reused after restoration. Graft survival, patient survival, kidney function, rejections, number of columns, adverse events after column reuse, and anti-A/anti-B antibody titers were assessed. Seventy-one ABO-incompatible patients underwent antigen-specific immunoadsorption and could be transplanted across the blood group barrier. Kaplan-Meier estimates for both, patient-censored and death-censored graft survivals were both 97.2% at 5 years. Allograft function was excellent with a mean estimated glomerular filtration rate of 54 mL per min after 1 year. The median number of pretransplant immunoadsorptions was 5. All centers performed column reuse. A total of 394 immunoadsorption procedures were performed with reused filters. Patient survival, graft survival, and adverse events did not differ when filters were reused. Column reuse resulted in cost savings of 21,458 USD per patient. We have introduced a national protocol for ABO-incompatible kidney transplantation including immunoadsorption column reuse. Column reuse was efficient and safe.Keywords
This publication has 18 references indexed in Scilit:
- Outcomes of ABO-Incompatible Kidney Transplantation in the United StatesTransplantation, 2012
- Anti-A/B antibody depletion by semiselective versus ABO blood group-specific immunoadsorptionNephrology Dialysis Transplantation, 2011
- Clinical Relevance of Pretransplant Donor-Specific HLA Antibodies Detected by Single-Antigen Flow-BeadsTransplantation, 2009
- Changes of Circulating Antibody Levels Induced by ABO Antibody Adsorption for ABO-Incompatible Kidney TransplantationAmerican Journal of Transplantation, 2009
- Banff 07 Classification of Renal Allograft Pathology: Updates and Future DirectionsAmerican Journal of Transplantation, 2008
- ABO‐incompatible kidney transplantation—Proposal of an intensified apheresis strategy for patients with high initial isoagglutinine titersJournal of Clinical Apheresis, 2007
- Clinical experience with a new apheresis filter that specifically depletes ABO blood group antibodiesTransfusion, 2006
- Classification of Surgical ComplicationsAnnals of Surgery, 2004
- Excellent Long-term Outcome of ABO-Incompatible Living Donor Kidney Transplantation in JapanAmerican Journal of Transplantation, 2004
- β‐Herpesvirus Challenges in the Transplant RecipientThe Journal of Infectious Diseases, 2002